MARK IRVING: Open Payments
NPI 1902227184 · LANCASTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 26 payments from 13 companies in 2025. Trend: 2023 $135 · 2024 $366 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $76 |
| Xeris Pharmaceuticals, Inc. | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Lilly USA, LLC | 3 | $44 |
| ABBVIE INC. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Exact Sciences Corporation | 2 | $29 |
| Corcept Therapeutics | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: Kerendia, GVOKE HYPOPEN, REXULTI, MOUNJARO, CAPLYTA, Cologuard Collection Kit, Korlym, UBRELVY.
Industry payments across OH — which companies pay providers there.
